|
|
|
|
|
|
Sponsored by: |
Federation Nationale des Centres de Lutte Contre le Cancer |
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00104702 |
RATIONALE: Radiation therapy uses high-energy x rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery.
PURPOSE: This phase II trial is studying how well radiation therapy works in treating older women who are undergoing surgery for stage I or stage II breast cancer.
Condition | Intervention | Phase |
Breast Cancer |
Procedure: adjuvant therapy Procedure: conventional surgery Procedure: radiation therapy |
Phase II |
Genetics Home Reference related topics: | breast cancer |
MedlinePlus related topics: | Breast Cancer Cancer |
Study Type: | Interventional |
Study Design: | Treatment, Open Label |
Official Title: | Radio-Surgical Treatment of Breast Cancer of Women Aged Over 70: Phase II Trial of Feasibility and Reproducibility of a Concentrated and Focalized Radiotherapy |
Estimated Enrollment: | 42 |
Study Start Date: | July 2004 |
Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter, open-label, nonrandomized study.
Patients undergo surgery. After surgery, patients undergo radiotherapy twice daily for 5 days.
PROJECTED ACCRUAL: A total of 42 patients will be accrued for this study.
Ages Eligible for Study: | 70 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Diagnosis of invasive breast cancer
Stage I or II disease
Tumor size ≤ 30 mm
Hormone receptor status
PATIENT CHARACTERISTICS:
Age
Sex
Menopausal status
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
France | |||||
Centre Alexis Vautrin | Recruiting | ||||
Vandoeuvre-les-Nancy, France, 54511 | |||||
Contact: Didier Peiffert, MD 33-3-8359-8434 d.peiffert@nancy.fnclcc.fr | |||||
Centre Antoine Lacassagne | Recruiting | ||||
Nice, France, 06088 | |||||
Contact: J. M. Hannoun-Levi, MD 33-4-9203-1260 | |||||
Centre Hospitalier Lyon Sud | Recruiting | ||||
Pierre Benite, France, 69495 | |||||
Contact: Pascale Romestaing, MD 33-4-78-86-42-51 pascale.romestaing@chu-lyon.fr | |||||
Centre Leon Berard | Recruiting | ||||
Lyon, France, 69373 | |||||
Contact: Xavier Montbarbon 33-4-7234-5703 | |||||
Centre Oscar Lambret | Recruiting | ||||
Lille, France, 59020 | |||||
Contact: Yazid Belkacemi, MD, PhD 33-3-20-29-55-53 y-belkacemi@o-lambret.fr | |||||
Institut Gustave Roussy | Recruiting | ||||
Villejuif, France, F-94805 | |||||
Contact: Hugo Marsiglia, MD 33-1-4211-4995 marsiglia@igr.fr | |||||
CHU Pitie-Salpetriere | Recruiting | ||||
Paris, France, 75651 | |||||
Contact: Jean-Marc Simon 33-142-178-174 | |||||
Hopital Saint-Louis | Recruiting | ||||
Paris, France, 75475 | |||||
Contact: Christophe Hennequin, PhD 33-1-4249-4949 christophe.hennequin@sls.ap-hop-paris.fr | |||||
Institut Bergonie | Recruiting | ||||
Bordeaux, France, 33076 | |||||
Contact: Laurence Thomas 33-5-5633-3333 | |||||
Centre Paul Strauss | Recruiting | ||||
Strasbourg, France, 67065 | |||||
Contact: Philippe Quetin 33-3-8825-2478 |
Federation Nationale des Centres de Lutte Contre le Cancer |
Investigator: | J. M. Hannoun-Levi, MD | Centre Antoine Lacassagne |
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
Study ID Numbers: | CDR0000416123, FRE-FNCLCC-GERICO-03/0303, EU-20501 |
First Received: | March 3, 2005 |
Last Updated: | July 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00104702 |
Health Authority: | Unspecified |
|
|
|